1. Home
  2. HSDT vs RVYL Comparison

HSDT vs RVYL Comparison

Compare HSDT & RVYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSDT
  • RVYL
  • Stock Information
  • Founded
  • HSDT N/A
  • RVYL 2007
  • Country
  • HSDT United States
  • RVYL United States
  • Employees
  • HSDT N/A
  • RVYL N/A
  • Industry
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RVYL Professional Services
  • Sector
  • HSDT Health Care
  • RVYL Consumer Discretionary
  • Exchange
  • HSDT Nasdaq
  • RVYL Nasdaq
  • Market Cap
  • HSDT 6.4M
  • RVYL 7.3M
  • IPO Year
  • HSDT N/A
  • RVYL N/A
  • Fundamental
  • Price
  • HSDT $22.75
  • RVYL $0.28
  • Analyst Decision
  • HSDT Hold
  • RVYL Hold
  • Analyst Count
  • HSDT 1
  • RVYL 1
  • Target Price
  • HSDT N/A
  • RVYL N/A
  • AVG Volume (30 Days)
  • HSDT 1.2M
  • RVYL 1.1M
  • Earning Date
  • HSDT 11-11-2025
  • RVYL 11-13-2025
  • Dividend Yield
  • HSDT N/A
  • RVYL N/A
  • EPS Growth
  • HSDT N/A
  • RVYL N/A
  • EPS
  • HSDT N/A
  • RVYL N/A
  • Revenue
  • HSDT $295,000.00
  • RVYL $48,904,000.00
  • Revenue This Year
  • HSDT N/A
  • RVYL $27.50
  • Revenue Next Year
  • HSDT $75.13
  • RVYL $35.71
  • P/E Ratio
  • HSDT N/A
  • RVYL N/A
  • Revenue Growth
  • HSDT N/A
  • RVYL N/A
  • 52 Week Low
  • HSDT $5.37
  • RVYL $0.25
  • 52 Week High
  • HSDT $1,200.00
  • RVYL $2.35
  • Technical
  • Relative Strength Index (RSI)
  • HSDT 86.15
  • RVYL 41.46
  • Support Level
  • HSDT $5.78
  • RVYL $0.27
  • Resistance Level
  • HSDT $24.49
  • RVYL $0.31
  • Average True Range (ATR)
  • HSDT 1.62
  • RVYL 0.02
  • MACD
  • HSDT 2.35
  • RVYL 0.00
  • Stochastic Oscillator
  • HSDT 90.70
  • RVYL 25.60

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

Share on Social Networks: